<qa>  What is the MCLA-128 given in combination in two metastatic breast cancer populations?MCLA-128 is given in combinations in two metastatic breast cancer MBC populations, HER2-positiveamplified Cohort 1 and Estrogen Receptor-positivelow HER2 expression Cohort2. 